499 related articles for article (PubMed ID: 20166978)
1. The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases?
Hirbe AC; Morgan EA; Weilbaecher KN
Curr Pharm Des; 2010; 16(11):1284-90. PubMed ID: 20166978
[TBL] [Abstract][Full Text] [Related]
2. CXCR4
Goto Y; Aoyama M; Sekiya T; Kakita H; Waguri-Nagaya Y; Miyazawa K; Asai K; Goto S
Stem Cells; 2016 Nov; 34(11):2733-2743. PubMed ID: 27339271
[TBL] [Abstract][Full Text] [Related]
3. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.
Wang J; Loberg R; Taichman RS
Cancer Metastasis Rev; 2006 Dec; 25(4):573-87. PubMed ID: 17165132
[TBL] [Abstract][Full Text] [Related]
4. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
[TBL] [Abstract][Full Text] [Related]
5. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.
Perissinotto E; Cavalloni G; Leone F; Fonsato V; Mitola S; Grignani G; Surrenti N; Sangiolo D; Bussolino F; Piacibello W; Aglietta M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):490-7. PubMed ID: 15701832
[TBL] [Abstract][Full Text] [Related]
6. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.
Wright LM; Maloney W; Yu X; Kindle L; Collin-Osdoby P; Osdoby P
Bone; 2005 May; 36(5):840-53. PubMed ID: 15794931
[TBL] [Abstract][Full Text] [Related]
7. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract][Full Text] [Related]
9. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.
Kucia M; Reca R; Miekus K; Wanzeck J; Wojakowski W; Janowska-Wieczorek A; Ratajczak J; Ratajczak MZ
Stem Cells; 2005 Aug; 23(7):879-94. PubMed ID: 15888687
[TBL] [Abstract][Full Text] [Related]
10. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.
Guleng B; Tateishi K; Ohta M; Kanai F; Jazag A; Ijichi H; Tanaka Y; Washida M; Morikane K; Fukushima Y; Yamori T; Tsuruo T; Kawabe T; Miyagishi M; Taira K; Sata M; Omata M
Cancer Res; 2005 Jul; 65(13):5864-71. PubMed ID: 15994964
[TBL] [Abstract][Full Text] [Related]
11. Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis.
Suratt BT; Petty JM; Young SK; Malcolm KC; Lieber JG; Nick JA; Gonzalo JA; Henson PM; Worthen GS
Blood; 2004 Jul; 104(2):565-71. PubMed ID: 15054039
[TBL] [Abstract][Full Text] [Related]
12. The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy.
Zhou Y; Cao HB; Li WJ; Zhao L
Chin J Nat Med; 2018 Nov; 16(11):801-810. PubMed ID: 30502762
[TBL] [Abstract][Full Text] [Related]
13. Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis.
Wang J; Wang J; Sun Y; Song W; Nor JE; Wang CY; Taichman RS
Cell Signal; 2005 Dec; 17(12):1578-92. PubMed ID: 16005185
[TBL] [Abstract][Full Text] [Related]
14. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2003 Aug; 18(8):1404-18. PubMed ID: 12929930
[TBL] [Abstract][Full Text] [Related]
15. The CXCR4/SDF-1 chemokine receptor axis: a new target therapeutic for non-small cell lung cancer.
Otsuka S; Bebb G
J Thorac Oncol; 2008 Dec; 3(12):1379-83. PubMed ID: 19057260
[TBL] [Abstract][Full Text] [Related]
16. ROS-Induced CXCR4 Signaling Regulates Mantle Cell Lymphoma (MCL) Cell Survival and Drug Resistance in the Bone Marrow Microenvironment via Autophagy.
Chen Z; Teo AE; McCarty N
Clin Cancer Res; 2016 Jan; 22(1):187-99. PubMed ID: 26350264
[TBL] [Abstract][Full Text] [Related]
17. Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.
Zhou W; Guo S; Liu M; Burow ME; Wang G
Curr Med Chem; 2019; 26(17):3026-3041. PubMed ID: 28875842
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell.
Wang Z; Sun J; Feng Y; Tian X; Wang B; Zhou Y
Tumour Biol; 2016 Jul; 37(7):8515-28. PubMed ID: 27079871
[TBL] [Abstract][Full Text] [Related]
19. SDF-1/CXCR4 axis in Tie2-lineage cells including endothelial progenitor cells contributes to bone fracture healing.
Kawakami Y; Ii M; Matsumoto T; Kuroda R; Kuroda T; Kwon SM; Kawamoto A; Akimaru H; Mifune Y; Shoji T; Fukui T; Kurosaka M; Asahara T
J Bone Miner Res; 2015 Jan; 30(1):95-105. PubMed ID: 25130304
[TBL] [Abstract][Full Text] [Related]
20. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion.
Libura J; Drukala J; Majka M; Tomescu O; Navenot JM; Kucia M; Marquez L; Peiper SC; Barr FG; Janowska-Wieczorek A; Ratajczak MZ
Blood; 2002 Oct; 100(7):2597-606. PubMed ID: 12239174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
